Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: May 27, 2017

DrugPatentWatch Database Preview

Fluocinonide - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for fluocinonide and what is the scope of fluocinonide patent protection?

is the generic ingredient in five branded drugs marketed by Taro, G And W Labs Inc, Fougera Pharms, Cnty Line Pharms, Teva, Teva Pharms, Fougera Pharms Inc, Fougera, Perrigo Israel, Medicis, Glenmark Generics, and Perrigo New York, and is included in thirty-one NDAs. There are five patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Fluocinonide has eleven patent family members in nine countries.

There are nine drug master file entries for fluocinonide. Thirty suppliers are listed for this compound.

Summary for Generic Name: fluocinonide

Drug Master File Entries: see list9
Suppliers / Packagers: see list30
Bulk Api Vendors: see list43
Clinical Trials: see list6
Patent Applications: see list4,754
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:fluocinonide at DailyMed

Pharmacology for Ingredient: fluocinonide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
CREAM;TOPICAL021758-001Feb 11, 2005ABRXYesYes7,794,738► Subscribe ► Subscribe
CREAM;TOPICAL072490-001Feb 7, 1989AB2RXNoNo► Subscribe► Subscribe
CREAM;TOPICAL021758-001Feb 11, 2005ABRXYesYes8,232,264► SubscribeY ► Subscribe
Fougera Pharms
CREAM;TOPICAL076586-001Jun 23, 2004AB2RXNoNo► Subscribe► Subscribe
Perrigo Israel
CREAM;TOPICAL090256-001Jan 14, 2014ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Predict branded drug patent expiration
  • Formulary management
  • Set up watchlists for daily email updates

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus